Windgap Medical
Windgap Medical offers autoinjector platforms that simplify, automate and accelerate the delivery of difficult-to-mix drugs, freeing patients, families and potential treatments from the limitations of current medical delivery technology. Its first product is for the administration of adrenaline for anaphylaxis, with additional products under development in a variety of markets.
Windgap Medical was founded in 2011 and is privately held.

